XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway

• Main Authors: Shengqi Wang (Author), Xiaoyan Liu (Author), Renlun Huang (Author), Yifeng Zheng (Author), Neng Wang (Author), Bowen Yang (Author), Honglin Situ (Author), Yi Lin (Author), Zhiyu Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Macrophages are the most abundant stromal cells associated with the host immune system in multiple malignancies including breast cancer. With proven clinical efficacy and no noticeable adverse effects, XIAOPI formula (XPS) has been approved for breast hyperplasia treatment by the State Food and Drug...